nonobviousness

Part Ⅴ analyzes the patentability of modern chimeras in terms of the statutory subject matter, novelty, nonobviousness, utility, and disclosure.

第五部分针对人生物之可专利性进行讨论，其包括法定标的、新颖性、非而易知性、实用性、及露充分性等。

Sections 102 and 103 of the Patent Act establish that ‘novelty’ and ‘nonobviousness’ (ie, an inventive step) are required for patentability.

《专利法》第102 及103 条规定，发项目若要获得专利，必须属于「崭新」和「不」（涉及发性的步骤）。